Clinical trial
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg…
NCT00496002 · Pharmasset, Industry · Terminated
Key facts
| NCT number | NCT00496002 |
|---|---|
| Title | Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus |
| Official title | A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus |
| Acronym | QUASH 1 |
| Lead sponsor | Pharmasset, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis, Hepatitis B |
| Intervention type | Drug |
| Interventions | Clevudine, Adefovir |
| Start date | Aug 1, 2007 |
| First posted | Jul 4, 2007 |
| Last update posted | Apr 27, 2009 |
| Countries | Argentina, Australia, Brazil, Canada, China, Greece, Puerto Rico, Spain, Taiwan, Thailand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: